Latest News & Features
Americas
A proposal in the North American Free Trade Agreement to set the length of biologic data exclusivity at ten years would harm patients, according to generic associations. 31 August 2018
Americas
A report released this week by non-profit MassBio has shown that Massachusetts companies “dominated” the landscape for US initial public offerings (IPOs) of biotech companies in 2017. 31 August 2018
Americas
Christopher Viehbacher was selected in the LSIPR 50 2018 publication for his influence on the life sciences industry. He featured in the investment section, as LSIPR reports. 31 August 2018
Americas
Iana Dimkova was selected in the LSIPR 50 2018 publication for her influence on the life sciences industry. She featured in the investment section, as LSIPR reports. 30 August 2018
Americas
Life sciences company Emergent BioSolutions announced plans to acquire Adapt Pharma earlier this week, in what the company said was an effort to combat the public health threat from opioid overdose. 30 August 2018
Americas
The US Food and Drug Administration has warned 21 websites over the illegal marketing of misbranded versions of opioid medications. 30 August 2018
Americas
Morgan Lewis & Bockius has expanded its IP practice by adding a patent prosecution and litigation team of lawyers from McDermott Will & Emery. 29 August 2018
Big Pharma
UK-based Horizon Discovery has entered into a CRISPR collaboration with an unnamed big pharma company. 29 August 2018
Americas
Purdue Pharma has settled another patent dispute involving pain drug OxyContin (oxycodone), just weeks after a suit against generics company Amneal Pharmaceuticals came to an end. 29 August 2018
article
Jean-François Formela was selected in the LSIPR 50 2018 publication for his influence on the life sciences industry. He featured in the investment section, as LSIPR reports. 29 August 2018